Literature DB >> 1285353

Angiofollicular lymph node hyperplasia: a comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis.

D M Menke1, J K Camoriano, P M Banks.   

Abstract

A morphometric and clinical analysis of 47 cases of angiofollicular lymph node hyperplasia (AFLH) demonstrated morphometric differences between plasma cell (28 cases) and hyaline vascular (19 cases) AFLH. Twenty-one AFLH cases were unicentric, and 26 cases were multicentric. Plasma cell types of AFLH, defined by standard morphologic and objective morphometric assessment, were associated with systemic clinical and laboratory abnormalities. Unicentric or hyaline vascular AFLH was amenable to surgical therapy, and multicentric or plasma cell AFLH without neuropathy was amenable to steroid treatment or chemotherapy with good prognoses. Multicentric or plasma cell AFLH with neuropathy was associated with resistance to steroids and chemotherapy and with a poor prognosis.

Entities:  

Mesh:

Year:  1992        PMID: 1285353

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  15 in total

1.  International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

Authors:  David C Fajgenbaum; Thomas S Uldrick; Adam Bagg; Dale Frank; David Wu; Gordan Srkalovic; David Simpson; Amy Y Liu; David Menke; Shanmuganathan Chandrakasan; Mary Jo Lechowicz; Raymond S M Wong; Sheila Pierson; Michele Paessler; Jean-François Rossi; Makoto Ide; Jason Ruth; Michael Croglio; Alexander Suarez; Vera Krymskaya; Amy Chadburn; Gisele Colleoni; Sunita Nasta; Raj Jayanthan; Christopher S Nabel; Corey Casper; Angela Dispenzieri; Alexander Fosså; Dermot Kelleher; Razelle Kurzrock; Peter Voorhees; Ahmet Dogan; Kazuyuki Yoshizaki; Frits van Rhee; Eric Oksenhendler; Elaine S Jaffe; Kojo S J Elenitoba-Johnson; Megan S Lim
Journal:  Blood       Date:  2017-01-13       Impact factor: 22.113

2.  Hyaline vascular-type Castleman's disease in the hepatoduodenal ligament: report of a case.

Authors:  Nagato Sato; Satoshi Kondo; Katsunori Saito; Satoshi Hirano; Takashi Hara; Eiichi Tanaka; Setsuyuki Ootake; Toshiaki Shichinohe; You Kawarada; Mikiya Takeuchi; Masaki Miyamoto; Toshiaki Morikawa
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

3.  FDG-PET imaging in the diagnosis of HIV-associated multicentric Castleman disease: something is still missing.

Authors:  Roberto Rossotti; Christina Moioli; Clara Schiantarelli; Carloandrea Orcese; Massimo Puoti
Journal:  Top Antivir Med       Date:  2012 Aug-Sep

4.  Histomorphologic Spectrum in Hyaline Vascular Variant of Castleman Disease.

Authors:  Chaithra Gowthuvalli Venkataramana; Hema Kini; Debarshi Saha; Sharada Rai; Deepa Sowkur Anandarama Adiga; Ranjitha Rao; Cheryl Sarah Philipose
Journal:  J Clin Diagn Res       Date:  2017-08-01

5.  Clinical spectrum of Castleman disease-associated neuropathy.

Authors:  Elie Naddaf; Angela Dispenzieri; Jay Mandrekar; Michelle L Mauermann
Journal:  Neurology       Date:  2016-11-02       Impact factor: 9.910

6.  Multimodality imaging and clinical features in Castleman disease: single institute experience in 30 patients.

Authors:  A J Hill; S H Tirumani; M H Rosenthal; A B Shinagare; R D Carrasco; N C Munshi; N H Ramaiya; S A Howard
Journal:  Br J Radiol       Date:  2015-02-24       Impact factor: 3.039

7.  Synchronous squamous cell carcinoma of tongue and unicentric cervical Castleman's disease clinically mimicking a stage IV disease: a rare association or coincidence?

Authors:  Mahesh Deshmukh; Munita Bal; Prashant Deshpande; N A Jambhekar
Journal:  Head Neck Pathol       Date:  2011-01-15

Review 8.  Comprehensive analysis of 225 Castleman's diseases in the oral maxillofacial and neck region: a rare disease revisited.

Authors:  Xiaotong He; Qiong Wang; Yaping Wu; Jiaan Hu; Dongmiao Wang; Bin Qi; Wei Zhang; Yanling Wang; Jie Cheng
Journal:  Clin Oral Investig       Date:  2017-10-04       Impact factor: 3.573

9.  The clinical spectrum of Castleman's disease.

Authors:  Angela Dispenzieri; James O Armitage; Matt J Loe; Susan M Geyer; Jake Allred; John K Camoriano; David M Menke; Dennis D Weisenburger; Kay Ristow; Ahmet Dogan; Thomas M Habermann
Journal:  Am J Hematol       Date:  2012-07-13       Impact factor: 10.047

10.  A multicentric, hyaline vascular variant of Castleman's disease associated with B cell lymphoma: a case report.

Authors:  Mehmet Ali Erkurt; Ismet Aydogdu; Irfan Kuku; Emin Kaya; Bulent Mizrak; Yalcin Basaran
Journal:  Cases J       Date:  2009-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.